Advocacy Partner: Pompe Alliance
About the Pompe Alliance
Pompe Alliance is a nonprofit organization dedicated to supporting individuals affected by Pompe disease, a rare and progressive genetic disorder. Founded in 2018, the organization aims to provide education, resources, and supportive services to patients, caregivers, medical professionals, and community stakeholders.
A few services that Pompe Alliance offers are information on treatment, advocates for those affected by the disease, provides financial assistance for durable medical equipment and travel to and from medical appointments, patient mentoring, and quarterly education/support groups. If you have any questions or would like additional information you can find us on Facebook and Instagram, and you can email us at [email protected]. You can also check out our website at www.pompealliance.com for additional information about our programs and services and to learn more about Pompe Disease.
Contact: Heather Shorten – Executive Director
Phone: 216-338-5736
Email: [email protected]
Resources
Pompe Alliance Financial Assistance Program
Pompe Alliance offers financial assistance to help people living with Pompe disease access essential equipment and support services.
Since 2020, the program has helped patients obtain durable medical equipment such as access ramps, motorized wheelchairs, manual wheelchairs, and lift chairs. Assistance may also be available for travel to and from medical appointments or to attend Pompe-related conferences and educational events.
If you are interested in applying for support, complete the application using the link below.
Upcoming events
About Advocacy Partners
The information above is provided by our partner. Learn more about our advocacy partners here.
Recent Posts
- Study finds milder heart issues in late-onset Pompe disease
- I’ve had to learn how to keep living in the waiting room of rare disease
- Pompe study ties high antibodies to infusion reaction risk
- Home infusions take us to as close to normal as I ever thought we’d get
- Immune changes seen in late-onset Pompe may affect treatment response
